Skip to Content
Corporate Sponsorships
Member Login
Search
Member Login
Give
Corporate Sponsorship
SEARCH
About Us
About ASTCT
Board of Directors
President Message
Partner Organizations
For Media
Contact ASTCT
Committees
Membership
Volunteer With ASTCT
Become a Member
Member Spotlights
Member Directory
Special Interest Groups
Community Forum
Mentor Match
Education
Practice Guidelines
Learning Center
Patient Education
Coverage, Coding, Billing
CAR-T Therapy Coding and Billing Guide
HCT Coding and Billing Resources
Payer RFI Forms
Meetings
Meetings
Meetings Calendar
Clinical Research Training Course
Fundamentals of Transplant and Cellular Therapy
Gene Therapy Summit
Publications & Podcasts
Journal: Transplantation and Cellular Therapy
Trending Topics: Nucleus
Podcast: ASTCT Talks
Newsletters
Tandem Meetings News
Careers
Career Center
Fellowship Programs
Fellowship Connections
Grants
Awards
Advocacy
ASTCT Advocacy
Policy Updates
Policy Letters and Statements
ACCESS Initiative
Hill Day
Trending topics and news in HCT and Cellular Therapy
Topics to Explore
ASTCT NEWS
CAR T
GVHD
TIL
SCIENCE HIGHLIGHTS
MORE TOPICS
BISPECIFICS
MRD
ASTCT News
Meet the Incoming Editor-in-Chief of Transplantation and Cellular Therapy, the official Journal of ASTCT: David L. Porter, MD
by Nucleus Staff
Incoming Transplantation and Cellular Therapy Editor-in-Chief David L. Porter, MD, shares his vision for the future of ASTCT’s official journal, discussing emerging advances in...
RECENT INSIGHTS
ASTCT News
Meet the Author: Miguel-Angel Pareles, MD, FASTCT — 'ASTCT Consensus Grading for Immune Effector Cell-Associated Toxicities 2026 Update'
by Miguel-Angel Perales
Miguel-Angel Perales, MD, FASTCT, is the senior author of “ASTCT Consensus Grading for Immune Effector Cell-Associated Toxicities 2026 Update.” In this Q&A, he discusses the...
TIL
Podcast: TIL Therapy in Sarcoma: From Tumor Procurement to Clinical Response
by ASTCT Talks
In this episode of ASTCT Talks, host Daniel Olson, MD, medical oncologist and co-leader of the melanoma, sarcoma, and solid tumor cellular therapy programs at the University of Chicago, is joined...